Trinity Medical Devices Inc., a private medical device company pioneering the emerging field of Generic Medical Devices; today announced that industry veterans Tony Dimun and Robert Coradini have been appointed as Directors of the Company.

“We are thrilled to welcome Tony and Bob to our Board of Directors, and look forward to their contributions to Trinity Medical Devices. As seasoned executives in the healthcare industry, Tony and Bob have significant leadership experience managing growing businesses, achieving sustainable revenue growth, driving operational improvements and acquiring strategic businesses for growth. I believe they will bring tremendous value to Trinity Medical Devices and to our Board of Directors as we pioneer generic medical devices. I also appreciate their vote of confidence by being significant investors in our company,” said John Easom, Chief Executive Officer of Trinity Medical.

About Tony Dimun

Mr. Dimun is a serial entrepreneur with more than 30 years of successful operational, business development, and financial experience in the healthcare marketplace. During the last 20 years, Mr. Dimun has been a founder, investor, director, and mentor to over 21 emerging growth medical enterprises that have matured to commercial status. Of these enterprises, four became public companies and eleven were acquired.

Since 2001, Mr. Dimun has served as Chairman and Founder of Nascent Enterprises, a group of medical industry entrepreneurs focused on successful commercialization of promising medical device inventions. From 1987 to 2001, he served as Executive Vice President & Chief Financial Officer and member of the BOD of Vital Signs, a publicly held anesthesia, respiratory and sleep apnea medical device business. GE Healthcare acquired Vital Signs in 2008 for approximately $900 million. Prior to 1991, Mr. Dimun held positions as a Certified Public Accountant with national accounting firms and served as Senior Vice President for an international merchant banking firm specializing in mergers & acquisitions.

Mr. Dimun has been a director of several public companies, including MELA Sciences, Vital Signs, Bionx Implants, Colorado MedTech, Photomedix, ISS Surgical Systems and other numerous privately held companies in the healthcare industry. He has also served on the Board of Advisors of the Rutgers University Technology Center & the Biomaterial Institute of Rutgers University and, through Nascent Enterprises, provides the University of Pennsylvania and other universities with entrepreneurial assistance to commercialize their medical technology.

“I am pleased to be joining Trinity Medical’s Board of Directors, and look forward to contributing to the company’s success,” said Mr. Dimun. “I personally know and have worked with John and the team while at Vital Signs and welcome the chance to reengage with them on this exciting opportunity. Trinity Medical is at an exciting stage in its development as a company. At this time in the medical device industry, having a company like Trinity that can offer high quality products, at more cost effective prices reducing costs in the supply chain; is critical to the survival of most healthcare providers. I’m pleased Trinity has achieved milestone success with numerous single use products and has impressively established strong long term business relationships with major medical device distribution partners.”

About Robert Coradini

Robert (Bob) Coradini, is President of Oak Tree Advisors, LLC., an advisory & consulting group for the global Healthcare & Biotech industry. He has done work with a number of companies that are either leaders in their field or developers of promising technology. Mr. Coradini has over 20 years experience in the health care industry, leading and managing businesses for Johnson & Johnson and GE Medical Systems (GE Healthcare) and recently served as interim CEO and Chairman of MELA Sciences.

Mr. Coradini was a former President of several Johnson & Johnson Companies, including Lifescan, Cordis Endovascular and Cardiovations, President of New Ventures for the J&J Consumer Group, and head of business development for J&J Medical Device & Diagnostics Group. He also ran OrthoNeutrogena and Colbar LifeSciences for J&J while being President of New Ventures of the Johnson & Johnson Consumer Group of Companies. Recently, the OrthoNeutrogena division was acquired by Valeant International.

Prior to J&J, Mr. Coradini was with General Electric for ten years, seven of which were with GE Medical Systems (GE Healthcare) a leader in diagnostic imaging. Mr. Coradini has also served on the Board of public companies MELA Sciences and WaferGen BioSystems as well as numerous private companies.

“I too am pleased to be joining Trinity Medical Devices as a Director, and have confidence in the approach they are taking to pioneer and lead in the up & coming field of Generic Medical Devices,” said Mr. Coradini. “I hope to bring my know-how, leadership skills and industry contacts to Trinity Medical with its well experienced team. Our common goal is to become a leader in this space especially as the need for reducing healthcare costs weigh heavily against healthcare providers, payers and patients worldwide.”

About Trinity Medical, Inc.

Trinity Medical Devices is an FDA registered, ISO 13485 certified, private medical device company focused on providing quality cost-effective alternatives in the commodity medical device market. Every year more products move from the specialty device category to the commodity category. The Company’s initial focus is in consumable anesthesia and respiratory products including masks, circuits, and breathing tubes.

It’s unique benefit is a single source supplier via access to Trinity’s Global network of ISO 13485 certified, FDA registered manufacturing partners, consolidating multiple order points and supplier qualifications to one US based contact.